{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:23:51Z","timestamp":1788344631013,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T00:00:00Z","timestamp":1494979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["HT9404-12-1-0020"],"award-info":[{"award-number":["HT9404-12-1-0020"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","award":["HU0001-14-1-0006"],"award-info":[{"award-number":["HU0001-14-1-0006"]}],"id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.vaccine.2017.05.016","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T09:02:58Z","timestamp":1496221378000},"page":"3672-3681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Deinococcus Mn2+-peptide complex: A novel approach to alphavirus vaccine development"],"prefix":"10.1016","volume":"35","author":[{"given":"Manoshi","family":"Gayen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paridhi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine M.","family":"Morazzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena K.","family":"Gaidamakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Knollmann-Ritschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha K.","family":"Maheshwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.05.016_b0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.chom.2012.05.011","article-title":"Preserving immunogenicity of lethally irradiated viral and bacterial vaccine epitopes using a radio- protective Mn2+-peptide complex from Deinococcus","volume":"12","author":"Gaidamakova","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2017.05.016_b0010","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nrmicro2073","article-title":"A new perspective on radiation resistance based on Deinococcus radiodurans","volume":"7","author":"Daly","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2017.05.016_b0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.dnarep.2011.10.024","article-title":"Death by protein damage in irradiated cells","volume":"11","author":"Daly","year":"2012","journal-title":"DNA Repair"},{"key":"10.1016\/j.vaccine.2017.05.016_b0020","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.dnarep.2016.05.024","article-title":"Protein oxidation, UVA and human DNA repair","volume":"44","author":"Karran","year":"2016","journal-title":"DNA Repair"},{"key":"10.1016\/j.vaccine.2017.05.016_b0025","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4269\/ajtmh.1999.60.441","article-title":"Genetic evidence for the origins of Venezuelan equine encephalitis virus subtype IAB outbreaks","volume":"60","author":"Weaver","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.05.016_b0030","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/oxfordjournals.aje.a117611","article-title":"The Cutter incident. Poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the Spring of 1955. II. Relationship of poliomyelitis to Cutter vaccine. 1963","volume":"142","author":"Nathanson","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2017.05.016_b0035","first-page":"103","article-title":"Review of accidents caused by incomplete inactivation of viruses","volume":"81","author":"Brown","year":"1993","journal-title":"Develop Biol Standard"},{"key":"10.1016\/j.vaccine.2017.05.016_b0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13104-015-1006-2","article-title":"Inactivation of non-enveloped virus by 1,5 iodonaphthyl azide","volume":"8","author":"Gupta","year":"2015","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.vaccine.2017.05.016_b0045","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.vaccine.2010.11.033","article-title":"Safety and protective efficacy of INA-inactivated Venezuelan equine encephalitis virus: implication in vaccine development","volume":"29","author":"Sharma","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.016_b0050","doi-asserted-by":"crossref","unstructured":"Hernandez R, Sinodis C, Brown DT. Sindbis virus: propagation, quantification, and storage. Curr Protocols Microbiol 2005;Chapter 15: Unit 15B.1.","DOI":"10.1002\/9780471729259.mc15b01s00"},{"key":"10.1016\/j.vaccine.2017.05.016_b0055","doi-asserted-by":"crossref","first-page":"e0160575","DOI":"10.1371\/journal.pone.0160575","article-title":"MDP: a deinococcus Mn2+-decapeptide complex protects mice from ionizing radiation","volume":"11","author":"Gupta","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2017.05.016_b0060","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1089\/ars.2012.5093","article-title":"Manganese complexes: diverse metabolic routes to oxidative stress resistance in prokaryotes and yeast","volume":"19","author":"Culotta","year":"2013","journal-title":"Antioxidants Redox Signal"},{"key":"10.1016\/j.vaccine.2017.05.016_b0065","doi-asserted-by":"crossref","first-page":"14373","DOI":"10.1073\/pnas.1009312107","article-title":"Protein damage and death by radiation in Escherichia coli and Deinococcus radiodurans","volume":"107","author":"Krisko","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.05.016_b0070","doi-asserted-by":"crossref","first-page":"e12570","DOI":"10.1371\/journal.pone.0012570","article-title":"Small-molecule antioxidant proteome-shields in Deinococcus radiodurans","volume":"5","author":"Daly","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2017.05.016_b0075","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00045391-200201000-00003","article-title":"Biological and chemical agents: a brief synopsis","volume":"9","author":"Rosenbloom","year":"2002","journal-title":"Am J Therapeutics"},{"key":"10.1016\/j.vaccine.2017.05.016_b0080","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(96)02275-1","article-title":"Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America VEE Study Group","volume":"348","author":"Weaver","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.05.016_b0085","first-page":"491","article-title":"Alphaviral equine encephalomyelitis (Eastern, Western and Venezuelan)","volume":"34","author":"Arechiga-Ceballos","year":"2015","journal-title":"Revue scientifique et technique (International Office of Epizootics)."},{"key":"10.1016\/j.vaccine.2017.05.016_b0090","unstructured":"CDC: Chikungunya virus in the United States: 2015 data. https:\/\/www.cdc.gov\/chikungunya\/geo\/united-states-2015.html2015"},{"key":"10.1016\/j.vaccine.2017.05.016_b0095","doi-asserted-by":"crossref","first-page":"e104915","DOI":"10.1371\/journal.pone.0104915","article-title":"Nowcasting the spread of chikungunya virus in the Americas","volume":"9","author":"Johansson","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2017.05.016_b0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4269\/ajtmh.14-0442","article-title":"Chikungunya virus infections among travelers-United States, 2010\u20132013","volume":"92","author":"Lindsey","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.05.016_b0105","unstructured":"Holley HP FD, Terpening SJ, Mallory RM, Main CA, Snow DM, Helber S. Safety of an Attenuated Venezuelan equine encephalitis virus (VEEV) vaccine in humans. In: The 48th Annual ICAAC\/IDSA 46th Annual Meeting. Washington D.C.; 2008."},{"key":"10.1016\/j.vaccine.2017.05.016_b0110","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4269\/ajtmh.1967.16.762","article-title":"Live, attenuated Venezuelan equine encephalomyelitis virus vaccine. I. Clinical effects in man","volume":"16","author":"Alevizatos","year":"1967","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.05.016_b0115","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1016\/j.vaccine.2016.04.077","article-title":"A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation","volume":"34","author":"Hannaman","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.016_b0120","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/viro.1995.1458","article-title":"Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1","volume":"212","author":"Davis","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2017.05.016_b0125","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(15)70043-5","article-title":"Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial","volume":"15","author":"Ramsauer","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.05.016_b0130","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/S0140-6736(14)61185-5","article-title":"Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial","volume":"384","author":"Chang","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.05.016_b0135","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1016\/j.vaccine.2012.08.025","article-title":"US Military contributions to the global response to pandemic chikungunya","volume":"30","author":"Hoke","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.016_b0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0264-410X(86)90003-4","article-title":"Development of an attenuated strain of chikungunya virus for use in vaccine production","volume":"4","author":"Levitt","year":"1986","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.016_b0145","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1016\/j.vaccine.2008.04.044","article-title":"Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates","volume":"26","author":"Fine","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.016_b0150","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4269\/ajtmh.2000.62.681","article-title":"Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218","volume":"62","author":"Edelman","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.05.016_b0155","doi-asserted-by":"crossref","first-page":"e1002142","DOI":"10.1371\/journal.ppat.1002142","article-title":"Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism","volume":"7","author":"Plante","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2017.05.016_b0160","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jviromet.2009.11.006","article-title":"A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV)","volume":"163","author":"Fine","year":"2010","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2017.05.016_b0165","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/icb.2011.70","article-title":"Return of inactivated whole-virus vaccine for superior efficacy","volume":"90","author":"Furuya","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2017.05.016_b0170","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1128\/JVI.80.6.2784-2796.2006","article-title":"Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN\/VEE viruses","volume":"80","author":"Paessler","year":"2006","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2017.05.016_b0175","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.vaccine.2009.10.126","article-title":"Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB","volume":"28","author":"Martin","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.016_b0180","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1128\/JCM.00761-13","article-title":"Fifty percent tissue culture infective dose assay for determining the titer of infectious human herpesvirus 8","volume":"51","author":"Nadgir","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2017.05.016_b0185","doi-asserted-by":"crossref","first-page":"12683","DOI":"10.1128\/JVI.01345-10","article-title":"Antibody to the E3 glycoprotein protects mice against lethal venezuelan equine encephalitis virus infection","volume":"84","author":"Parker","year":"2010","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2017.05.016_b0190","doi-asserted-by":"crossref","first-page":"e1003312","DOI":"10.1371\/journal.ppat.1003312","article-title":"Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus","volume":"9","author":"Pal","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2017.05.016_b0195","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.micron.2017.02.004","article-title":"Effects of radiation damage in studies of protein-DNA complexes by cryo-EM","volume":"96","author":"Mishyna","year":"2017","journal-title":"Micron (Oxford, England: 1993)"},{"key":"10.1016\/j.vaccine.2017.05.016_b0200","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1128\/jb.63.4.473-485.1952","article-title":"The properties of x-ray inactivated bacteriophage","volume":"63","author":"Watson","year":"1952","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2017.05.016_b0205","doi-asserted-by":"crossref","first-page":"e5336","DOI":"10.1371\/journal.pone.0005336","article-title":"Intranasal flu vaccine protective against seasonal and H5N1 avian influenza infections","volume":"4","author":"Alsharifi","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2017.05.016_b0210","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1128\/iai.26.1.131-136.1979","article-title":"Gamma-irradiated scrub typhus immunogens: broad-spectrum immunity with combinations of rickettsial strains","volume":"26","author":"Eisenberg","year":"1979","journal-title":"Infect Immunity"},{"key":"10.1016\/j.vaccine.2017.05.016_b0215","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1128\/AEM.00081-11","article-title":"Inactivation of a human norovirus surrogate, human norovirus virus-like particles, and vesicular stomatitis virus by gamma irradiation","volume":"77","author":"Feng","year":"2011","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2017.05.016_b0220","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1089\/088282402760312340","article-title":"Ultraviolet-irradiated vaccinia virus recombinants, exposing HIV-envelope on their outer membrane, induce antibodies against this antigen in rabbits","volume":"15","author":"Loewinger","year":"2002","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2017.05.016_b0225","unstructured":"Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications. Guidance for Industry: Food and Drug Administration; 2010."},{"key":"10.1016\/j.vaccine.2017.05.016_b0230","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0264-410X(97)00192-8","article-title":"Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates","volume":"16","author":"Pratt","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.016_b0235","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.vaccine.2013.01.014","article-title":"A chimeric Sindbis-based vaccine protects cynomolgus macaques against a lethal aerosol challenge of eastern equine encephalitis virus","volume":"31","author":"Roy","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.016_b0240","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/297070a0","article-title":"Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis","volume":"297","author":"Schmaljohn","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.05.016_b0245","doi-asserted-by":"crossref","DOI":"10.4269\/ajtmh.16-0635","article-title":"Mosquito exposure and chikungunya and dengue infection among travelers during the chikungunya outbreak in the Americas","author":"Lindholm","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.05.016_b0250","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1097\/QAD.0000000000001200","article-title":"Non-neutralizing antibody functions for protection and control HIV in humans and SIV and SHIV in non-human primates","volume":"30","author":"Zolla-Pazner","year":"2016","journal-title":"AIDS (London, England)"},{"key":"10.1016\/j.vaccine.2017.05.016_b0255","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chom.2016.05.014","article-title":"Both neutralizing and non-neutralizing human H7N9 influenza vaccine-induced monoclonal antibodies confer protection","volume":"19","author":"Henry Dunand","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2017.05.016_b0260","doi-asserted-by":"crossref","first-page":"44727","DOI":"10.1038\/srep44727","article-title":"The immune correlates of protection for an avian influenza H5N1 vaccine in the ferret model using oil-in-water adjuvants","volume":"7","author":"Wong","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2017.05.016_b0265","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1099\/vir.0.038281-0","article-title":"Early activation of the host complement system is required to restrict central nervous system invasion and limit neuropathology during Venezuelan equine encephalitis virus infection","volume":"93","author":"Brooke","year":"2012","journal-title":"J General Virol"},{"key":"10.1016\/j.vaccine.2017.05.016_b0270","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/j.vaccine.2015.04.102","article-title":"Inactivated and subunit vaccines against porcine reproductive and respiratory syndrome: current status and future direction","volume":"33","author":"Renukaradhya","year":"2015","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2017.05.016_b0275","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.clindermatol.2014.12.009","article-title":"Cutaneous reactions to vaccinations","volume":"33","author":"Rosenblatt","year":"2015","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.vaccine.2017.05.016_b0280","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1016\/j.vaccine.2014.08.032","article-title":"Investigations into an outbreak of suppurative lymphadenitis with BCG vaccine SSI((R)) in Singapore","volume":"32","author":"Soh","year":"2014","journal-title":"Vaccine"}],"updated-by":[{"DOI":"10.1016\/j.vaccine.2026.128880","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:00:00Z","timestamp":1788048000000}}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17306242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17306242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:03:43Z","timestamp":1786021423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17306242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":56,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0264410X17306242"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deinococcus Mn2+-peptide complex: A novel approach to alphavirus vaccine development","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}